Related Experiment Video
Updated: Jun 4, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Circular RNA circPFKP suppress gastric cancer progression through targeting miR-346/CAMD3 axis
Xin Song1, Guochao Zhang1, Jinwei Niu1
1General Surgery department, China-Japan Friendship Hospital, 2 Yinghua East Street, Chaoyang District, Beijing, 100029, PR China.
Abstract:
Studies have demonstrated that circular RNAs (circRNAs) exert an important regulatory function in the pathogenesis of various tumors. However, their role in gastric cancer (GC) is still not completely understood. In our study, the differentially expressed circRNAs in GC tissues and matched adjacent normal tissues were analyzed by utilizing gene chips GSE93541, GSE89143, and GSE78092. The expression of has_circ_0006608 (circPFKP), miR-346, and CAMD3 was analyzed through quantitative real-time polymerase chain reaction (qRT-PCR). The CCK-8 assay and Transwell assay were employed to detect the effect of circPFKP on the proliferation, migration, and invasion of gastric cancer cells. The mice xenograft assay was used to assess the function of circPFKP in vivo. The targeting relationship between circPFKP, miR-346, and CAMD3 was predicted by bioinformatics analysis and confirmed by the dual-luciferase reporter assay and RNA pull-down assay. Our results screened and verified that circPFKP was down-regulated in gastric cancer tissues and cells. Overexpression of circPFKP in GC cells can inhibit cell proliferation, migration, invasion, and tumor growth in vivo. Additionally, circPFKP has been shown to act as a sponge for miR-346 to modulate the expression of CAMD3. Finally, we demonstrated that overexpression of CAMD3 or miR-346 inhibitor significantly reversed the effects of si-circPFKP on the proliferation, migration, and invasion of gastric cancer cells. In conclusion, this study provided that circPFKP inhibits the progression of GC via the miR-346/CAMD3 axis, this may provide a noval biomarker for the diagnosis and treatment of GC.
Insights
Circular RNAs (circRNAs) regulate tumor development. This study found circPFKP inhibits gastric cancer progression by targeting the miR-346/CAMD3 pathway, offering a potential diagnostic and therapeutic biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) play a role in tumor pathogenesis, but their specific function in gastric cancer (GC) remains unclear.
- Gastric cancer is a significant global health concern, necessitating further research into its underlying molecular mechanisms.
Purpose of the Study:
- To investigate the role and mechanism of circPFKP in gastric cancer.
- To identify potential diagnostic and therapeutic targets for GC.
Main Methods:
- Differential expression analysis of circRNAs using gene chips (GSE93541, GSE89143, GSE78092).
- Quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression analysis.
- In vitro (CCK-8, Transwell assays) and in vivo (mice xenograft assay) functional studies.
- Bioinformatics, dual-luciferase reporter, and RNA pull-down assays to confirm molecular interactions.
Main Results:
- circPFKP was found to be downregulated in GC tissues and cells.
- Overexpression of circPFKP suppressed GC cell proliferation, migration, invasion, and tumor growth in vivo.
- circPFKP functions as a molecular sponge for miR-346, thereby regulating CAMD3 expression.
- Upregulation of CAMD3 or inhibition of miR-346 reversed the anti-cancer effects of circPFKP.
Conclusions:
- circPFKP inhibits gastric cancer progression through the miR-346/CAMD3 axis.
- circPFKP represents a potential novel biomarker for GC diagnosis and treatment.
Related Concept Videos
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity

